(1 - 8 von 13
)
Blueprint Medicines' AYVAKYT® (avapritinib) Receives ...Blueprint Medicines
ir.blueprintmedicines.com
— ... Georg Pirmin Meyer , M.D., Senior Vice President, International at Blueprint Medicines . "We believe that AYVAKYT has the potential to shift ...
Blueprint Medicines Announces European Commission ...RTTNews
www.rttnews.com
— Georg Pirmin Meyer, Senior Vice President, International at Blueprint Medicines, said: "For the first time in Europe ISM patients have an — Georg Pirmin Meyer, Senior Vice President, International at Blueprint Medicines, said: "For the first time in Europe ISM patients have an ...
Blueprint Medicines announces approval of AYVAKYT for ...News-Medical
www.news-medical.net
— Georg Pirmin Meyer, M.D., Senior Vice President, International at Blueprint Medicines. “Indolent systemic mastocytosis can be characterized — Georg Pirmin Meyer, M.D., Senior Vice President, International at Blueprint Medicines. “Indolent systemic mastocytosis can be characterized ...
Blueprint Medicines' AYVAKYT® (avapritinib) Receives ...Ariva
www.ariva.de
— ... Georg Pirmin Meyer, M.D., Senior Vice President, International at Blueprint Medicines. "For the first time in Europe ISM patients have an — ... Georg Pirmin Meyer, M.D., Senior Vice President, International at Blueprint Medicines. "For the first time in Europe ISM patients have an ...
sortiert nach Relevanz / Datum